Janssen 'Doublespeak' Fueled Opioid Crisis, NJ Suit Says
Janssen Pharmaceuticals Inc. fanned the flames of the opioid crisis by using an elaborate campaign of deceptive marketing, including "doublespeak" that touted the company's opioid painkillers as unlike most opioids, New...To view the full article, register now.
Already a subscriber? Click here to view full article